NCT07418385

Brief Summary

Since 2020, an increase in positive screenings for sexually transmitted infections, including HIV, has been observed. Voluntary early screening plays an important role in the national strategy for HIV care in France. There are currently several methods that allow patients to undergo voluntary screening.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
1mo left

Started Oct 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress91%
Oct 2025Sep 2026

Study Start

First participant enrolled

October 7, 2025

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

February 11, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 18, 2026

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 7, 2026

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2026

Expected
Last Updated

February 18, 2026

Status Verified

February 1, 2026

Enrollment Period

6 months

First QC Date

February 11, 2026

Last Update Submit

February 17, 2026

Conditions

Human Immunodeficiency Virus (HIV)

Keywords

HIVvoluntary screening

Outcome Measures

Primary Outcomes (1)

  • The method(s) used for undergoing voluntary HIV testing questionnaire

    The method(s) used for undergoing voluntary HIV testing: medical prescription, Center for Free Information, Testing, and Diagnosis, medical laboratory, rapid diagnostic test (RDT), or self-test

    Day 0

Interventions

data collectionsOTHER

data collections

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Subjects aged 18 years or older, whether or not they have previously undergone voluntary HIV testing, residing in France, and agreeing to participate in the study.

You may qualify if:

  • years of age or older
  • Male or female
  • Regardless of sexual orientation
  • Whether or not they have previously undergone voluntary HIV testing
  • Agreeing to participate in the study.

You may not qualify if:

  • Minors
  • Refusing to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ufr Medecine Urca

Reims, 51100, France

RECRUITING

MeSH Terms

Conditions

Acquired Immunodeficiency Syndrome

Condition Hierarchy (Ancestors)

HIV InfectionsBlood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesSlow Virus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Central Study Contacts

Gestonnairedu CURRS

CONTACT

0326918822currs@univ-reims.fr

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 11, 2026

First Posted

February 18, 2026

Study Start

October 7, 2025

Primary Completion

April 7, 2026

Study Completion (Estimated)

September 1, 2026

Last Updated

February 18, 2026

Record last verified: 2026-02

Locations

FR(1)